Strs Ohio Sage Therapeutics, Inc. Transaction History

Strs Ohio

$25.5 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 31, 2023	BUY	$40.65 - $59.54 $296,745 - $434,642	7,300 New	7,300 $343,000
Q3 2022 Oct 27, 2022	SELL	$32.28 - $43.27 $103,296 - $138,464	-3,200 Reduced 40.51%	4,700 $184,000
Q2 2022 Jul 25, 2022	BUY	$27.52 - $37.99 $217,408 - $300,121	7,900 New	7,900 $255,000
Q3 2021 Oct 22, 2021	SELL	$40.26 - $57.37 $929,724 - $1.32 Million	-23,093 Closed	0 $0
Q2 2021 Jul 26, 2021	BUY	$54.88 - $79.29 $661,304 - $955,444	12,050 Added 109.12%	23,093 $1.31 Million
Q1 2021 Apr 23, 2021	BUY	$70.65 - $96.76 $780,187 - $1.07 Million	11,043 New	11,043 $826,000
Q1 2020 Apr 23, 2020	SELL	$26.15 - $77.24 $1.36 Million - $4.02 Million	-52,000 Closed	0 $0
Q4 2019 Jan 24, 2020	SELL	$60.18 - $154.77 $1.66 Million - $4.28 Million	-27,642 Reduced 34.71%	52,000 $3.75 Million
Q3 2019 Oct 21, 2019	SELL	$140.29 - $189.96 $6.02 Million - $8.15 Million	-42,901 Reduced 35.01%	79,642 $11.2 Million
Q2 2019 Jul 25, 2019	SELL	$157.85 - $183.09 $12.1 Million - $14.1 Million	-76,957 Reduced 38.57%	122,543 $22.4 Million
Q1 2019 Apr 19, 2019	SELL	$89.33 - $163.65 $2.72 Million - $4.99 Million	-30,500 Reduced 13.26%	199,500 $31.7 Million
Q4 2018 Jan 23, 2019	BUY	$81.94 - $139.71 $7.18 Million - $12.2 Million	87,583 Added 61.5%	230,000 $22 Million
Q3 2018 Oct 19, 2018	BUY	$138.11 - $169.04 $16.7 Million - $20.5 Million	121,206 Added 571.43%	142,417 $20.1 Million
Q2 2018 Aug 06, 2018	SELL	$140.36 - $175.76 $1.3 Million - $1.63 Million	-9,289 Reduced 30.46%	21,211 $3.32 Million
Q1 2018 Apr 20, 2018	BUY	$152.15 - $192.33 $289,085 - $365,427	1,900 Added 6.64%	30,500 $4.91 Million
Q4 2017 Jan 23, 2018	SELL	$60.72 - $167.34 $2.51 Million - $6.91 Million	-41,300 Reduced 59.08%	28,600 $4.71 Million
Q3 2017 Oct 23, 2017	BUY	$61.4 - $88.52 $4.29 Million - $6.19 Million	69,900	69,900 $4.35 Million

Others Institutions Holding SAGE

# of Institutions

198

Shares Held

46.5M

Call Options Held

402K

Put Options Held

209K

View Full List

About Sage Therapeutics, Inc.

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $323M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

More about SAGE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Strs Ohio with notifications on news.

Account